Robert Stephen Flack
Impact in
-
- Advanced Breast Cancer Therapies
- Lung Cancer Treatments and Mutations
-
- Cancer-related Molecular Pathways
Papers in
-
- Advanced Breast Cancer Therapies 1
- Sarcoma Diagnosis and Treatment 1
- Oncology 1
- Cancer-related Molecular Pathways 1
- Co-authors
- Philip W. Iversen (2 shared papers)Lawrence M. Gelbert (1 shared paper)Rose T. Ajamie (1 shared paper)Graham N. Wishart (1 shared paper)Alfonso de Dios (1 shared paper)Raquel Torres (1 shared paper)Xi Lin (1 shared paper)Emiko L. Kreklau (1 shared paper)
- Journals
- Investigational New Drugs (1 paper)Clinical Cancer Research (1 paper)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesSpainUnited Kingdom
In The Last Decade
Robert Stephen Flack
3 papers receiving 616 citations
Robert Stephen Flack's Hit Papers
Peers
Comparison fields: 5 of 52
- Pulmonary and Respiratory Medicine 351
- Oncology 109
- Genetics 22
- Cancer Research 25
- Molecular Biology 107
Countries citing papers authored by Robert Stephen Flack
This map shows the geographic impact of Robert Stephen Flack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Stephen Flack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Stephen Flack more than expected).
Fields of papers citing papers by Robert Stephen Flack
This network shows the impact of papers produced by Robert Stephen Flack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Stephen Flack. The network helps show where Robert Stephen Flack may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Stephen Flack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine Hit paper breakdown → | 2014 | 488 |
| 2 | 2019 | 89 | |
| 3 | 2018 | 53 |
About Robert Stephen Flack
Robert Stephen Flack is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 3 papers that have together received 630 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (1 paper), Sarcoma Diagnosis and Treatment (1 paper), Melanoma and MAPK Pathways (1 paper) and Cancer-related Molecular Pathways (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (351 citations), Oncology (109 citations), Genetics (22 citations), Cancer Research (25 citations) and Molecular Biology (107 citations). Robert Stephen Flack has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include Philip W. Iversen, Lawrence M. Gelbert, Rose T. Ajamie, Graham N. Wishart, Alfonso de Dios, Raquel Torres, Xi Lin, Emiko L. Kreklau, Blake Lee Neubauer and Damien M. Cronier. Their work appears in journals such as Investigational New Drugs, Clinical Cancer Research and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.